Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

(2013) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

GPER-1 Expression Decreases During Breast Cancer Tumorigenesis

(2013) Tanja Ignatov et al.   CANCER INVESTIGATION

G Protein-Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor-Positive Breast Cancer Patients

(2013) S. Broselid et al.   CLINICAL CANCER RESEARCH

Post-synaptic Density-95 (PSD-95) Binding Capacity of G-protein-coupled Receptor 30 (GPR30), an Estrogen Receptor That Can Be Identified in Hippocampal Dendritic Spines

(2013) Keith T. Akama et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection

(2013) Patricia M Lenhart et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

GPER-1 acts as a tumor suppressor in ovarian cancer

(2013) Tanja Ignatov et al.   Journal of Ovarian Research

Optimizing high-resolution melting analysis for the detection of mutations of GPR30/GPER-1 in breast cancer

(2012) Masamune Aihara et al.   GENE

Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

(2012) Aleix Prat et al.   JOURNAL OF CLINICAL ONCOLOGY

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

(2012) Zuzana Kolkova et al.   Journal of Ovarian Research

GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer

(2012) Satoe Fujiwara et al.   Journal of Ovarian Research

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

(2011) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

Biologic markers determine both the risk and the timing of recurrence in breast cancer

(2011) Laura J. Esserman et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

(2011) P-L Jerevall et al.   BRITISH JOURNAL OF CANCER

Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways

(2011) Ross D. Feldman et al.   BRITISH JOURNAL OF PHARMACOLOGY

The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells

(2010) E. A. Ariazi et al.   CANCER RESEARCH

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

(2009) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

(2009) Deo Prakash Pandey et al.   EMBO JOURNAL

G Protein-Coupled Receptor 30: Estrogen Receptor or Collaborator?

(2009) Ellis R. Levin   ENDOCRINOLOGY

GPR30 predicts poor survival for ovarian cancer

(2009) Harriet O. Smith et al.   GYNECOLOGIC ONCOLOGY

GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients

(2009) Maria Giess et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

A critical review of fundamental controversies in the field of GPR30 research

(2009) Gernot Langer et al.   STEROIDS

GPR30/GPER1: searching for a role in estrogen physiology

(2009) Björn Olde et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice

(2008) S. H. Windahl et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

G Protein-Coupled Receptor 30 Localizes to the Endoplasmic Reticulum and Is Not Activated by Estradiol

(2008) Christiane Otto et al.   ENDOCRINOLOGY

Deletion of the G Protein-Coupled Receptor 30 Impairs Glucose Tolerance, Reduces Bone Growth, Increases Blood Pressure, and Eliminates Estradiol-Stimulated Insulin Release in Female Mice

(2008) Ulrika E. A. Mårtensson et al.   ENDOCRINOLOGY